Platelets

• Bell CE, Botteman MF, Gao X et al.  Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States.  Clin Ther 2003:25(9):2464-86.
  > View abstract
   
• Moeremans K, Warie H, Annemans L.  Assessment of the economic value of the INTERCEPT Blood System in Belgium.  Transfus Med 2006;16(1):17-30.
  > View abstract
   
• Postma MJ, van Hulst M, De Wolf JT et al.  Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands. Transfus Med 2005;15(5):379-87.
  > View abstract
   
• Staginnus U, Corash L.  Economics of pathogen inactivation technology for platelet concentrates in Japan.  Int J Hematol 2004;80(4):317-24.
  > View abstract